Drug Evaluation Committee 146th Annual Meeting of the Committee on Drug Evaluation "Patient and Public Involvement" to be considered now - For whom our activities are for
Nov 28, 2024
- 01_To Find "Hope" Together (Mr. Matsumoto, Ehime Cancer Support Orenji no Kai)(2.04MB)
- 02_Pharmaceuticals and Patient/Citizen Engagement (Dr. Muto, Institute of Medical Science, University of Tokyo)(1.89MB)
- 03. Introduction of the efforts of the Pharmaceutical Manufacturers Association of Japan (Dr. Misawa, Chairperson of the Patient Organization Collaboration Promotion Committee)(1.43MB)
- 04. Introduction of activities by the Pharmaceutical Manufacturers Association of Japan (Drug Evaluation Committee, Chairperson: Mr. Nakaji) (3.28MB) (in Japanese only)
- 05_Introduction of activities by the Pharmaceutical Manufacturers Association of Japan (Mr. Matsuzawa, Chairperson, Clinical Evaluation Committee)(3.38MB)
- 06_Introduction of activities by the Pharmaceutical Manufacturers Association of Japan (Dr. Miyazaki, Chairperson, PV Subcommittee) (2.94MB) (in Japanese)
- 07_Introduction of activities by the Pharmaceutical Manufacturers Association of Japan (Dr. Aoyama, Chairperson, MA Sub-committee) (1.90MB) (in Japanese)